We next determined the mechanistic linkage of the levels of mtNPM1 on the lethal activity of MI, exportin-1 inhibitor, or the conventional DNA-damaging anti-AML drugs, including cytarabine and daunorubicin. This evidence concerns the gene XPO1 and acute myeloid leukemia.